Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Negri · SciRah

Researcher profile · Semantic Scholar

F. Negri

Share profile

F. Negri — researcher profile on SciRah

h-index: 26
Works: 88
Citations: 2,512

Most-cited papers

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.
L. Rimassa, E. Assenat, M. Peck-Radosavljevic, M. Pracht +26 more
2018The Lancet Oncology300 citations
Semantic Scholar
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.
R. Castriconi, Alessandra Dondero, R. Augugliaro, C. Cantoni +8 more
2004Proceedings of the National Academy of Sciences of the United States of America300 citations Open access
Semantic Scholar
Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer.
F. Negri, A. Wotherspoon, D. Cunningham, A. Norman +2 more
2005Annals of Oncology159 citations Open access
Semantic Scholar
Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma
C. Bozzetti, F. Negri, C. Lagrasta, P. Crafa +10 more
2011British Journal of Cancer152 citations Open access
Semantic Scholar
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib
A. Gardini, E. Scarpi, L. Faloppi, M. Scartozzi +9 more
2016OncoTarget97 citations Open access
Semantic Scholar
Immunotherapy for colorectal cancer: where are we heading?
D. Basile, S. Garattini, M. Bonotto, E. Ongaro +18 more
2017Expert Opinion on Biological Therapy94 citations Open access
Semantic Scholar
PTEN status in advanced colorectal cancer treated with cetuximab
F. Negri, C. Bozzetti, C. Lagrasta, P. Crafa +4 more
2009British Journal of Cancer86 citations Open access
Semantic Scholar
Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy
F. Negri, N. Campanini, R. Camisa, F. Pucci +9 more
2007British Journal of Cancer84 citations Open access
Semantic Scholar
Both CD133+ and CD133– medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK‐mediated cytotoxicity
R. Castriconi, Alessandra Dondero, F. Negri, F. Bellora +6 more
2007European Journal of Immunology78 citations Open access
Semantic Scholar
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis
M. Scartozzi, I. Bearzi, A. Mandolesi, Chiara Pierantoni +12 more
2009BMC Cancer75 citations Open access
Semantic Scholar
Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases
C. Gambini, M. Conte, G. Bernini, P. Angelini +13 more
2003Virchows Archiv74 citations Open access
Semantic Scholar
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study.
F. Loupakis, R. Intini, C. Cremolini, A. Orlandi +40 more
2019European Journal of Cancer66 citations Open access
Semantic Scholar
Molecular classifications of gastric cancers: Novel insights and possible future applications
S. Garattini, D. Basile, M. Cattaneo, V. Fanotto +13 more
2017World Journal of Gastrointestinal Oncology64 citations Open access
Semantic Scholar
Expression of pERK and VEGFR‐2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
F. Negri, B. dal Bello, C. Porta, N. Campanini +8 more
2015Liver international (Print)57 citations
Semantic Scholar
KRAS: A Druggable Target in Colon Cancer Patients
F. Negri, L. Bottarelli, G. de'Angelis, L. Gnetti
2022International Journal of Molecular Sciences52 citations Open access
Semantic Scholar
HER‐2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma
C. Bozzetti, N. Personeni, R. Nizzoli, A. Guazzi +7 more
2003Cancer44 citations Open access
Semantic Scholar
GDNF deficit in Hirschsprung's disease.
G. Martucciello, H. Thompson, C. Mazzola, A. Morando +6 more
1998Journal of Pediatric Surgery44 citations Open access
Semantic Scholar
Microsatellite instability in colorectal cancer
G. D. de’ Angelis, L. Bottarelli, C. Azzoni, N. de'Angelis +4 more
2018Acta bio-medica : Atenei Parmensis41 citations
Semantic Scholar
Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma Group
K. Mazzocco, R. Defferrari, A. Sementa, A. Garaventa +15 more
2015Pediatric Blood & Cancer36 citations
Semantic Scholar
HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
V. Fanotto, E. Ongaro, K. Rihawi, A. Avallone +13 more
2016OncoTarget35 citations Open access
Semantic Scholar
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?
G. Aprile, F. Negri, F. Giuliani, E. De Carlo +11 more
2017Critical reviews in oncology/hematology33 citations Open access
Semantic Scholar
Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.
A. Pezzolo, E. Rossi, S. Gimelli, Federica Parodi +7 more
2009Neuro-Oncology31 citations Open access
Semantic Scholar
Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: the development of a preoperative chemotherapy strategy.
F. Negri, A. Musolino, D. Cunningham, U. Pastorino +2 more
2004Clinical colorectal cancer29 citations
Semantic Scholar
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy
F. Negri, A. Musolino, N. Naldi, B. Bortesi +10 more
2013The Pharmacogenomics Journal27 citations Open access
Semantic Scholar
Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma
M. Corrias, Stefano Parodi, R. Haupt, L. Lacitignola +9 more
2008British Journal of Cancer27 citations Open access
Semantic Scholar
Successful isolation and long‐term establishment of a cell line with stem cell‐like features from an anaplastic medulloblastoma
A. Raso, F. Negri, A. Gregorio, P. Nozza +8 more
2008Neuropathology and Applied Neurobiology26 citations
Semantic Scholar
Epidermal growth factor receptor and Kras gene expression: Reliability of mutational analysis on cytological samples
C. Bozzetti, F. Negri, C. Azzoni, N. Naldi +7 more
2013Diagnostic Cytopathology23 citations
Semantic Scholar
Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer
L. Laghi, F. Negri, F. Gaiani, T. Cavalleri +3 more
2020International Journal of Molecular Sciences22 citations Open access
Semantic Scholar
Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes
F. Gaiani, F. Marchesi, F. Negri, L. Greco +3 more
2021International Journal of Molecular Sciences21 citations Open access
Semantic Scholar
Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting survival.
L. Ampollini, L. Gnetti, M. Goldoni, L. Viani +15 more
2017Journal of Thoracic Disease21 citations Open access
Semantic Scholar
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial.
S. Cascinu, R. Berardi, R. Bianco, D. Bilancia +21 more
2021European Journal of Cancer17 citations
Semantic Scholar
Liquid biopsy to predict benefit from rechallenge with cetuximab (cet) + irinotecan (iri) in RAS/BRAF wild-type metastatic colorectal cancer patients (pts) with acquired resistance to first-line cet+iri: Final results and translational analyses of the CRICKET study by GONO.
D. Rossini, C. Cremolini, E. Conca, M. Del Re +16 more
201817 citations
Semantic Scholar
Subgroup analyses in RAS mutant, BRAF mutant and all-wt mCRC pts treated with FOLFOXIRI plus bevacizumab (bev) or FOLFIRI plus bev in the TRIBE study.
F. Loupakis, C. Cremolini, S. Lonardi, G. Tomasello +16 more
201417 citations
Semantic Scholar
Wilms' tumor arising in a multicystic kidney
M. Oddone, C. Marino, C. Sergi, M. Occhi +5 more
2005Pediatric Radiology17 citations
Semantic Scholar
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
F. Negri, C. Bozzetti, G. Pedrazzi, C. Azzoni +14 more
2019Oncology Report15 citations Open access
Semantic Scholar
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol
A. Gardini, L. Faloppi, G. Aprile, O. Brunetti +28 more
2018Tumori15 citations Open access
Semantic Scholar
Detection of Transplacental Melanoma Metastasis Using Quantitative PCR
A. Raso, S. Mascelli, P. Nozza, R. Biassoni +6 more
2010Diagnostic molecular pathology (Print)15 citations
Semantic Scholar
Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded?
R. Giampieri, M. Caporale, F. Pietrantonio, F. De Braud +9 more
2016Critical reviews in oncology/hematology14 citations
Semantic Scholar
Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research
F. Negri, G. Missale, A. Antoni, C. Porta
2021Translational Oncology13 citations Open access
Semantic Scholar
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): Updated survival results and final molecular subgroups analyses.
F. Loupakis, C. Cremolini, C. Antoniotti, S. Lonardi +16 more
201513 citations
Semantic Scholar
Expression of HER2/neu is uncommon in human neuroblastic tumors and is unrelated to tumor progression
C. Gambini, A. Sementa, L. Boni, C. Marino +5 more
2003Cancer Immunology and Immunotherapy12 citations Open access
Semantic Scholar
Liquid biopsy allows predicting benefit from rechallenge with cetuximab(cet)+irinotecan(iri) in RAS/BRAF wild-type mCRC patients(pts) with resistance to 1st-line cet+iri: Final results and translational analyses of the CRICKET study by GONO.
D. Rossini, C. Cremolini, E. Conca, M. Del Re +16 more
2018Annals of Oncology11 citations Open access
Semantic Scholar
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer.
F. Negri, P. Crafa, G. Pedrazzi, C. Bozzetti +17 more
2015Future Oncology11 citations
Semantic Scholar
Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?
F. Negri, L. Gnetti, G. Pedrazzi, E. Silini +1 more
2021Future Oncology10 citations
Semantic Scholar
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?
F. Negri, L. Bottarelli, G. Pedrazzi, M. Maddalo +14 more
2023Frontiers in Oncology9 citations Open access
Semantic Scholar
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil.
F. Negri, C. Azzoni, L. Bottarelli, N. Campanini +8 more
2013Anticancer Research9 citations
Semantic Scholar
O-0026FOLFOXIRI/BEVACIZUMAB VERSUS FOLFIRI/BEVACIZUMAB AS FIRST-LINE TREATMENT IN UNRESECTABLE METASTATIC COLORECTAL CANCER: RESULTS OF PHASE III TRIBE TRIAL BY GONO GROUP
C. Cremolini, F. Loupakis, G. Masi, S. Lonardi +18 more
20139 citations Open access
Semantic Scholar
Preoperative enzymo-histochemical diagnosis of dysganglionoses associated with anorectal malformations (ARM) with recto-vestibular and recto-perineal fistula.
G. Martucciello, C. Mazzola, A. Favre, F. Negri +5 more
1999European journal of pediatric surgery9 citations
Semantic Scholar
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series
F. Negri, A. De Giorgi, Annalisa Gilli, C. Azzoni +10 more
2019Scientific Reports8 citations Open access
Semantic Scholar
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients
V. Catalano, F. Bergamo, C. Cremolini, B. Vincenzi +15 more
2019Journal of Cancer Research and Clinical Oncology8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Scartozzi×10
Invite
M. Scartozzi — researcher profile on SciRah
S. Cascinu×10
Invite
S. Cascinu — researcher profile on SciRah
L. Bottarelli×8
Invite
L. Bottarelli — researcher profile on SciRah
C. Bozzetti×7
Invite
C. Bozzetti — researcher profile on SciRah

×7

Invite

D. Santini — researcher profile on SciRah

Invite

F. Loupakis — researcher profile on SciRah

Invite

G. Aprile — researcher profile on SciRah

C. Cremolini×7

Invite

C. Cremolini — researcher profile on SciRah

Invite

C. Azzoni — researcher profile on SciRah

Invite

P. Crafa — researcher profile on SciRah

N. Silvestris×6

Invite

N. Silvestris — researcher profile on SciRah

Invite

A. Falcone — researcher profile on SciRah